Please login to the form below
Ledaga
This page shows the latest Ledaga news and features for those working in and with pharma, biotech and healthcare.
EU nod for Actelion's skin cancer drug Ledaga
Still need to meet CHMP post-approval requirements. Actelion has won EU approval for Ledaga, a drug to treat a rare form of lymphoma that manifests itself in the skin, but ... The Swiss biotech - which already sells Ledaga (mechlorethamine or chlormethine
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Gilead to pay $745m for three oncology programmes from Arcus Biosciences
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn
- US demand for COVID-19 antibody treatments rising fast
- Lucid Group: Orange the World
- First trial of a vaccine against Alzheimer’s launches
- New COVID variant causing concern
- PMEA 2021: A Celebration of Excellence in Patient Engagement
- From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn
- AstraZeneca/Moderna’s mRNA treatment for heart failure looks promising
- First trial of a vaccine against Alzheimer’s launches
- Gilead to pay $745m for three oncology programmes from Arcus Biosciences
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
